None listed
Conditions
Brief summary
The SMuRFless CAD Registry is a study involving patients referred to an National Health & Medical Research Council (NHMRC) Centre for Research Excellence (CRE) for Coronary Artery Disease (CAD) clinic: a specialty clinic of patients with diagnosed or suspected atherosclerotic CAD. The SMuRFless CAD Registry seeks to measure and improve quality of care in SMuRFless CAD patients utilising traditional and applied data linkage methods for key longitudinal endpoints, to determine the clinical and cost effectiveness of the NHMRC CRE clinical pathway in identifying risk factors of CAD progression and to understand risk factors for outcomes and regional/centre differences.
Interventions
Participants in the SMuRFless CAD Registry will complete a questionnaire at the time of enrolment either electronically on on paper, depending on his or her preference, which is expected to take approximately 15-20 minutes. In addition, information from the participant's SMuRFless CAD clinic visit will be recorded in the registry. Participants will be invited to provide informed consent for Medicare Benefits Schedule (MBS) / Pharmaceutical Benefits Scheme (PBS) data linkage to assess outcomes at 5-years, including major adverse cardiovascular events (MACE) and changes in medications after the SMuRFless CAD clinic visit. Participants who return to the SMuRFless CAD clinic for a clinically indicated visit will be invited to complete a questionnaire during this visit for the SMuRFless CAD Registry. This questionnaire can also be completed electronically or by paper form and is expected to take approximately 5-10 minutes.
Sponsors
Eligibility
Inclusion criteria
• 18 years of age or older • A clinically indicated visit to an NHMRC CRE for CAD clinic • Diagnosed or suspected atherosclerotic coronary artery disease (CAD), based on invasive coronary angiography or CT coronary angiography findings, or a family member of an individual with diagnosed CAD • Willing and able to provide informed consent by self
Exclusion criteria
• Prior medical diagnosis of hypertension • Prior medical diagnosis of hyperlipidaemia • Prior medical diagnosis of diabetes mellitus • History of tobacco smoking within the past 12 months • Patients highly dependent on medical care and unable to provide informed consent • People with cognitive impairment, intellectual disability, or mental illness that prevent them from providing informed consent for themselves